American Heart Association

bacteria microbiome
June 20, 2019

Microbiome links diet to health

Vanderbilt researchers have discovered that the gut microbiome composition modulates how dietary nutrients are metabolized, with potential downstream consequences on metabolic health.

By Niyati Vachharajani
June 10, 2019

Cell-cell signals in developing heart

Scott Baldwin and colleagues have discovered early signaling events during heart development, findings that could guide cell replacement therapies for heart disease.

By Leigh MacMillan
April 24, 2019

Study merges big data and zebrafish biology to reveal mechanisms of human disease

In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease.

By Leigh MacMillan
March 28, 2019

Cancer prevention drug also disables H. pylori bacterium

A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.

By Leigh MacMillan
February 21, 2019

AHA statement supports vascular cardio-oncology

The American Heart Association (AHA) has issued a scientific statement calling for the integration of cardio-oncology and vascular medicine to provide cancer patients and cancer survivors with optimal cardiovascular care.

By Tom Wilemon
January 24, 2019

Hypertension Center receives AHA certification

The Vanderbilt Comprehensive Hypertension Center has been awarded the American Heart Association’s Comprehensive Hypertension Center Certification, to recognize the practice’s commitment to following proven, research-based treatment guidelines to care for people with complex or difficult-to-treat hypertension, or high blood pressure.

By Matt Batcheldor
January 17, 2019

Signals from the “conveyor belt”

Vanderbilt researchers propose that cellular signaling pathways are amplified by a “conveyor belt” mechanism that exchanges active and inactive enzymes.
By Bill Snyder
December 13, 2018

Lean vs. obese adipose tissue cells

A greater understanding of the mechanisms and cell types involved in returning adipose (fatty) tissue to the lean state may lead to more effective treatments for obesity.
By Bill Snyder
November 15, 2018

Vanderbilt study suggests way to prevent rare lung disease

Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.
By Bill Snyder
November 15, 2018

Harrison awarded AHA Basic Research Prize for 2018

David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.
By Bill Snyder
September 27, 2018

Stretch, inflammation and hypertension

New research sheds light on how changes in blood vessel forces enhance immune cell activation and promote hypertension.
By VUMC News and Communications
September 10, 2018

Greater Nashville Heart Walk set for Sept. 15

The Greater Nashville Heart Walk is set for Saturday, Sept. 15 on the Vanderbilt campus to raise money and awareness about cardiovascular disease and stroke.
By Jessica Pasley
September 5, 2018

Unleashing TIGER on small RNAs

Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.
By Leigh MacMillan